<main class="html-publication" lang="en" role="main">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--single-identity brand__border-color" href="/government/organisations/uk-health-security-agency">
      <span class="gem-c-organisation-logo__name">UK Health<br>Security<br>Agency</span>
</a>
</div>
        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  

<div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>


  <h1 class="gem-c-title__text govuk-heading-xl">
    General product information and how to administer immunoglobulin (issued August 2020)
  </h1>
</div>
  <p class="publication-header__last-changed">Updated 4 May 2022</p>

  </header>



<div class="govuk-grid-row sidebar-with-body" data-module="sticky-element-container">
    <div class="govuk-grid-column-one-quarter-from-desktop contents-list-container">
        <nav aria-label="Contents" class="gem-c-contents-list" data-module="gem-track-click" role="navigation">
    <h2 class="gem-c-contents-list__title">
      Contents
</h2>
    <ol class="gem-c-contents-list__list">
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 1" data-track-category="contentsClicked" data-track-label="#general-information" data-track-options="{&quot;dimension29&quot;:&quot;General information&quot;}" href="#general-information">General information</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 2" data-track-category="contentsClicked" data-track-label="#administration-of-immunoglobulin" data-track-options="{&quot;dimension29&quot;:&quot;Administration of immunoglobulin&quot;}" href="#administration-of-immunoglobulin">Administration of immunoglobulin</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 3" data-track-category="contentsClicked" data-track-label="#administration-of-rabies-immunoglobulin-rig" data-track-options="{&quot;dimension29&quot;:&quot;Administration of rabies immunoglobulin (RIG)&quot;}" href="#administration-of-rabies-immunoglobulin-rig">Administration of rabies immunoglobulin (RIG)</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 4" data-track-category="contentsClicked" data-track-label="#normal-and-specific-immunoglobulin" data-track-options="{&quot;dimension29&quot;:&quot;Normal and specific immunoglobulin&quot;}" href="#normal-and-specific-immunoglobulin">Normal and specific immunoglobulin</a>

        </li>
    </ol>
</nav>
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>

  <div class="print-wrapper">
    <div class="print-meta-data">
      <p>
  <img class="print-meta-data-licence" src="/assets/government-frontend/open-government-licence-min-93b6a51b518ff99714a1aa2a7d2162735c155ec3cb073c75fb88b2a332fa83d3.png">
</p>
<p>
  Â© Crown copyright 2022
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/publications/immunoglobulin-when-to-use/general-product-information-and-how-to-administer-immunoglobulin-issued-august-2020
</p>


    </div>
  </div>

  <div class="main-content-container">
    <div class="gem-c-govspeak-html-publication">
  
<div class="gem-c-govspeak govuk-govspeak " data-module="govspeak">
    
    
      <div class="govspeak">
<h2>General information</h2>

<p>This document was originally published as the Immunoglobulin handbook in 2008 and the full history of updates to the guidance are available on <a class="govuk-link" href="https://www.gov.uk/government/publications/immunoglobulin-when-to-use#history">GOV.UK</a>.</p>

<p>The human immunoglobulin preparations prepared by Bio Products Limited (<abbr title="Bio Products Limited">BPL</abbr>) issued by the UK Health Security Agency (<abbr title="UK Health Security Agency">UKHSA</abbr>) and NHS laboratories are prepared from pooled plasma from non-UK blood donors.</p>

<p>Non-UK pooled plasma has been used since March 1999 due to theoretical risk of the transmission of new variant Creutzfeldt-Jakob disease (<abbr title="new variant Creutzfeldt-Jakob disease">nvCJD</abbr>).</p>

<p>All immunoglobulins are prepared from <abbr title="human immunodeficiency virus">HIV</abbr>, hepatitis B and hepatitis C negative donors.</p>

<p>Subgam (human normal immunoglobulin) (<abbr title="human normal immunoglobulin">HNIG</abbr>) from Bio Products Laboratory (<abbr title="Bio Products Limited">BPL</abbr>) is not licensed for prophylactic use against hepatitis A, measles or rubella. The product is, however, known to contain similar levels of measles antibody as licensed products.</p>

<p>The levels of hepatitis A antibody are around half the level of the licensing requirements for such a product (although higher than some other available <abbr title="human normal immunoglobulin">HNIG</abbr> preparations) but global supplies of suitable products are limited. Therefore <abbr title="UK Health Security Agency">UKHSA</abbr> is recommending the use of Subgam for hepatitis A prophylaxis but at a higher dose.</p>

<p>The following preparations for intramuscular use are held centrally by Movianto and ordered through the Rabies and Immunoglobulin Service (<abbr title="Rabies and Immunoglobulin Service">RIgS</abbr>).</p>

<p>Colindale (telephone number: 0330 128 1020, 8am to 5:30 pm) for delivery via ImmForm, and also by certain regional <abbr title="UK Health Security Agency">UKHSA</abbr> and NHS laboratories:</p>

<ul>
  <li>human normal immunoglobulin</li>
  <li>human varicella-zoster immunoglobulin</li>
  <li>human hepatitis B immunoglobulin</li>
  <li>human rabies immunoglobulin</li>
  <li>diphtheria antitoxin</li>
</ul>

<p>The following intramuscular preparations are available and are chargeable through <abbr title="Bio Products Limited">BPL</abbr> (telephone number: 020 8258 2200, 24 hours):</p>

<ul>
  <li>human tetanus immunoglobulin*</li>
  <li>human anti-D immunoglobulin</li>
  <li>human hepatitis B immunoglobulin**</li>
  <li>human rabies immunoglobulin**</li>
  <li>human varicella-zoster immunoglobulin**</li>
</ul>

<p>*Only tetanus immunoglobulin for IM use is now available from <abbr title="Bio Products Limited">BPL</abbr>. An IV tetanus immunoglobulin product is no longer available.</p>

<p>**These immunoglobulin preparations are available from <abbr title="UK Health Security Agency">UKHSA</abbr> although they can be purchased directly from <abbr title="Bio Products Limited">BPL</abbr> where clinicians wish to use them outside of the national Joint Committee of Vaccination and Immunisation (<abbr title="Joint Committee of Vaccination and Immunisation">JCVI</abbr>) guidance.</p>

<p>Tetanus specific immunoglobulin (<abbr title="tetanus specific immunoglobulin">TIG</abbr>) should be used for the treatment and prevention of tetanus if suitable stock can be sourced. However, where <abbr title="tetanus specific immunoglobulin">TIG</abbr> cannot be obtained, <abbr title="UK Health Security Agency">UKHSA</abbr> recommends that human normal immunoglobulin (IV and IM) preparations can be used. Further details about this are available in <a class="govuk-link" href="https://www.gov.uk/government/publications/tetanus-advice-for-health-professionals">Tetanus: guidance for health professionals</a>.</p>

<p>Vaccines, antitoxins and immunoglobulins are purchased by the Department of Health and Social Care (<abbr title="Department of Health and Social Care">DHSC</abbr>) specifically for use within the NHS. Similarly products distributed by <abbr title="UK Health Security Agency">UKHSA</abbr> on behalf of the department are provided for use within the NHS.</p>

<p>Only patients eligible for NHS treatment (those with an NHS number) are eligible to receive immunoglobulin products free of charge. Overseas patients can receive products through an NHS Hospital or by temporary registration with a GP.</p>

<p>Private clinics and hospitals are advised to secure stocks of the products they require directly from the manufacturers.</p>

<p>Supplies of normal immunoglobulin for intravenous administration may be obtained from the manufacturers. Details are available in the <a class="govuk-link" href="https://bnf.nice.org.uk/guidance/index-of-manufacturers.html" rel="external">British National Formulary Index of Manufacturers</a>.</p>

<p>For dosage, precautions, contraindications and side effects please refer to individual product information.</p>

<h2>Administration of immunoglobulin</h2>

<p>When a large volume injection, such as an intramuscular preparation of immunoglobulin is to be given, this should be administered deeply into a large muscle mass such as the anterolateral aspect of the thigh. The upper outer quadrant of the buttock can also be used for immunoglobulin injection.</p>

<p>If more than 3ml is to be given to young children and infants or more than 5ml to older children and adults, the immunoglobulin should be divided into smaller amounts and given into different sites.</p>

<h2>Administration of rabies immunoglobulin (<abbr title="rabies immunoglobulin">RIG</abbr>)</h2>

<p>As much <abbr title="rabies immunoglobulin">RIG</abbr> as possible should be infiltrated into the depth of the wound and around the site of the wound, with the rest of the <abbr title="rabies immunoglobulin">RIG</abbr> given in the anterolateral thigh. Where more than 3mls is to be given to young children or more than 5mls to older children and adults the immunoglobulin should be divided and given at different sites.</p>

<p>Vaccine and <abbr title="rabies immunoglobulin">RIG</abbr> must never be given at the same anatomical site, but can be given on the same day. <abbr title="rabies immunoglobulin">RIG</abbr> is not given after seven days post initiation of rabies <abbr title="post-exposure prophylaxis">PEP</abbr> vaccine (or to an individual who is already partially immunised).</p>

<p>See specific advice on administration of rabies immunoglobulin available on <a class="govuk-link" href="https://www.gov.uk/government/collections/rabies-risk-assessment-post-exposure-treatment-management">GOV.UK</a>.</p>

<h2>Normal and specific immunoglobulin</h2>

<p>Advice on the use of normal immunoglobulin for:</p>

<ul>
  <li>hepatitis A</li>
  <li>measles</li>
  <li>rubella</li>
  <li>polio</li>
</ul>

<p>and specific immunoglobulins for:</p>

<ul>
  <li>varicella-zoster</li>
  <li>hepatitis B</li>
  <li>rabies</li>
  <li>tetanus</li>
</ul>

<p>is also contained in <a class="govuk-link" href="https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book">Immunisation against Infectious Disease</a> (the Green Book). Further advice on the diseases and indications for immunoglobulin should be sought from this publication or the individual disease guidance found on <a class="govuk-link" href="https://www.gov.uk/government/publications/immunoglobulin-when-to-use">GOV.UK</a>.</p>

</div>


</div>
</div>
  </div>

  <div class="sticky-element" data-sticky-element="">
    <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" focusable="false" height="17" viewBox="0 0 13 17" width="13" xmlns="http://www.w3.org/2000/svg">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Contents
</a>

    <div class="sticky-element__print-link">
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>
  </div>
</div>

    </main>